Keeping at least one meter apart and wearing face masks and eye protection are the best ways to cut the risk of COVID-19 infection, according to the largest review to date of studies on coronavirus disease transmission.
COVID-19 is many things. It is creating an economic impact like we have never seen before, it’s a lesson in basic hygiene, a test in societal patience, an enormous challenge, and a rare opportunity. It also demonstrates why many have chosen the pharmaceutical profession.
Gilead Sciences has been overwhelmed with requests for remdesivir to treat cases of COVID-19, the disease caused by the novel coronavirus.
A global coalition set up to fight emerging epidemics will give $19 million to drugmaker Johnson & Johnson’s vaccine unit and Oxford University experts to work on immunizations against three major diseases.
A global coalition set up during 2017 to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed 12 people in India.
A private British company is developing a vaccine that would be the first in the world to fight all types of flu.
Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.
Anyone who goes down with flu in Europe this winter could be asked to enroll in a randomized clinical trial in which they will either be given a drug, which may or may not work, or standard advice to take bed rest and paracetamol. Those who agree could be helping the world prepare for the […]
The United States and Saudi Arabia are discussing the possibility of readying a vaccine for Middle East Respiratory Syndrome (MERS) before the next outbreak of the disease, the head of the World Health Organization (WHO) said on Tuesday. Margaret Chan said there were many gaps in the science of MERS and so far the world […]
Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus. The fund would help bridge the gap between early stage drug discovery work carried out at universities and small […]